Clinical Trials Browser

Phase 1 × Recurrence × trastuzumab deruxtecan × Clear all

NCT07015697 2026-03-20

A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

Phase 1 Recruiting

Recurrence